SCENIHR’s updated opinion concerns the safety of DEHP-plasticised polyvinylchloride (PVC)-containing medical devices, particularly for “at-risk” groups including neonates. The health effects of a number of alternative plasticisers are also assessed. SCENIHR concludes that the replacement of DEHP in medical devices should be considered “taking account the efficacy of the treatment”, and the toxicological profile and leaching potential of any alternative materials.

European Commission (2015). Scientific Committee on Emerging and Newly Identified Health Risks. The safety of medical devices containing DEHP-plasticized PVC or other plasticizers on neonates and other groups possibly at risk (2015 update). The SCENIHR adopted this opinion during the plenary meeting of 25 June 2015. http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_047.pdf
The above items were taken from the August 2015 issue of Toxicology and Regulatory News which is sent automatically to members of bibra (click here)

News Home Guest Write For Us? Contact Us